Antimetastatic effects of a leukocyte intracellular inhibitor of neutral proteases.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Cancer Research

• Publication date

  1977-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 908024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice.

  1977cited by this paper
• Lysosomal enzyme inhibitors and antimetastatic activity in the mouse.

  1977cited by this paper
• Intracellular distribution of neutral proteinases and inhibitors in pig leucocytes. Isolation of two inhibitors of neutral proteinases.

  1975cited by this paper
• Effect of cysteine on the survival of mice with transplanted malignant thymoma

  1974cited by this paper
• Anti-tumour Activity of Aprotinin

  1974cited by this paper
• PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS

  1972cited by this paper

• Epidermal SH-protease inhibitor (ACPI, cystatin A) in cancer. A short historical review.

  2010cites this paper
• The haematogenous spread of tumor: A prevental process

  2004cites this paper
• The haematogenous spread of tumor: A prevental process

  2004cites this paper
• On the prevention of haematogenous tumor metastases in rats the role of the proteinase inhibitor “Trasylol”

  2004cites this paper
• Deficiency of N-acetyl-β-d-glucosaminidase in neutrophils of cancer patients

  2004cites this paper
• Hemostasis and Malignancy

  1998cites this paper
• Difference in the distribution of low-molecular-weight peptides and amino-acids in normal and malignant-cells and tissues.

  1994cites this paper
• The reactivity and mechanism of action of triazenes (review)

  1994cites this paper
• Chemoprevention of cancer: protease inhibitors.

  1992cites this paper
• Therapy of Metastasis in Animal Models

  1989cites this paper
• Haemostasis and cancer.

  1989cites this paper
• A serine proteinase inhibitor produced by an HTLV I virus-transformed human T lymphocyte line.

  1987cites this paper
• Isoelectric equilibrium properties of normal and malignant cells and biological macromolecules.

  1986cites this paper
• Human Leucocyte Urokinase Inhibitor - Purification, Characterization and Comparative Studies Against Different Plasminogen Activators

  1985cites this paper
• Plasma proteinase inhibitors in Morris hepatoma-bearing rats: changes in the blood level and synthesis in tissue slices.

  1985cites this paper
• [Behavior of small molecular cysteine proteinase inhibitors in lung cancers and surrounding tissue].

  1984cites this paper
• Das Verhalten der kleinmolekularen Cysteinproteinase-Inhibitoren in Lungencarcinomen und den sie umgebenden Geweben

  1984cites this paper
• The Role of Hemostasis and Fibrinolysis in the Metastatic Spread of Cancer

  1984cites this paper
• [Proteolytic enzymes and their inhibitors in clinical and experimental oncology].

  1984cites this paper
• Deficiency of N-acetyl-beta-D-glucosaminidase in neutrophils of cancer patients.

  1984cites this paper
• Primary tumor growth and formation of spontaneous lung metastases in mice bearing Lewis carcinoma treated with proteinase inhibitors.

  1984cites this paper
• Lysosomal enzymes of neutrophils in women with breast cancer.

  1983cites this paper
• Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes.

  1983cites this paper
• Antibodies to plasminogen activator inhibit human tumor metastasis.

  1983cites this paper
• Some further characteristics of endogenous proteinase inhibitors.

  1982cites this paper
• Methodologic Problems Encountered in the Assay of Proteinases in Lewis Lung Carcinoma, a Mouse Metastasizing Tumor

  1982cites this paper
• Biochemical and biological characteristics of leucocyte proteinase inhibitors.

  1982cites this paper
• Chromogenic substrate assay for plasminogen activator activity of human oesophageal carcinoma cell lines.

  1982cites this paper
• Selective antimetastatic drugs (review).

  1981cites this paper
• Antimetastatic effects and tumor proteinase inhibition by spleen intracellular inhibitors of neutral proteinases.

  1981cites this paper
• INTRACELLULAR NEUTRAL PROTEINASES AND INHIBITORS

  1981cites this paper
• MALIGNANCY AND TUMOR PROTEINASES: EFFECTS OF PROTEINASE INHIBITORS

  1981cites this paper
• Prophylactic Antimetastatic Agents: Dimethyltriazenes, N-Diazoacetylglicine Derivatives and other Neutral Proteinase Inhibitors

  1980cites this paper
• Neutral proteinase inhibitors and antimetastatic effects in mice.

  1980cites this paper
• Mechanism of the antimetastatic action of N-diazoacetylglycinamide in mice bearing Lewis lung carcinoma.

  1980cites this paper
• Secretion of proteinases from malignant and nonmalignant human breast tissue.

  1980cites this paper
• Epidermal SH-protease inhibitor in human neoplasms and their metastases.

  1980cites this paper
• Proteolytic Enzymes and Plasminogen Activator in Melanoma

  1979cites this paper
• Selective antimetastatic effects of N-diazoacetylglycine derivatives in mice.

  1979cites this paper
• The intracellular enzymatic response of neutrophils and lymphocytes in patients with precancerous states and cancer of the larynx.

  1979cites this paper
• Biochemical and biological properties of leukocyte intracellular inhibitors of proteinases.

  1979cites this paper
• Dietary and nutritional implications in the multifactorial etiology of certain prevalent human cancers

  1979cites this paper
• Mechanisms of metastasis.

  1979cites this paper
• Intracellular defect of neutrophils in patients with cancer.

  1979cites this paper
• Inhibition studies of an intracellular inhibitor on thiol proteinases.

  1978cites this paper
• Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.

  1978cites this paper